Sikich 2021 — Intranasal Oxytocin in Children and Adolescents With Autism

New England Journal of Medicine·October 14, 2021

Linmarie Sikich, et al.

Summary

Intranasal oxytocin did not show meaningful benefit on social or cognitive function in children and adolescents with autism spectrum disorder.

Study Details

Study Design

24-week placebo-controlled phase 2 trial

Indication

Autism spectrum disorder

Intervention

Intranasal oxytocin vs placebo

Species

Human

Sample Size

290 subjects